Sign In
Buy CNS
$80.79
-1.71 (-2.07%)
At Close: Jul 21, 2026
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For May 2024
04:20pm, Monday, 10'th Jun 2024
NEW YORK , June 10, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $80.5 billion as of May 31, 2024, an increase of $3.3 billion from asse
Acadia Pharmaceuticals: Bullish On Nuplazid And Daybue Driven Growth In CNS Treatments
11:46pm, Wednesday, 05'th Jun 2024
ACADIA Pharmaceuticals is a biopharmaceutical company specializing in CNS disorder treatments, with two successful FDA-approved commercial products, Nuplazid and Daybue. Nuplazid, indicated for Parkin
VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induced obesity (DIO) mice
Cohen & Steers Appoints Daniel Noonan as Head of Wealth Management Consulting Group
09:00am, Wednesday, 05'th Jun 2024
NEW YORK , June 5, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) has named Daniel Noonan as Executive Vice President and Head of the Wealth Management Consulting Group. In this role, Mr.
The 4 Factor Dividend Growth Strategy - Cooling Off In The Second Half Of Fiscal Year 2
08:25am, Tuesday, 04'th Jun 2024
The 4-factor dividend growth portfolio is a strategy that leverages the stock selection process of Schwab U.S. Dividend Equity ETF with a few minor twists. The portfolio gained 1.28% in May, trailing
Cohen & Steers and DLC Management Acquire Open-Air Shopping Center Complex in Fayetteville, Arkansas
09:00am, Monday, 03'rd Jun 2024
NEW YORK , June 3, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that an affiliate of Cohen & Steers Capital Management, Inc. ("Cohen & Steers") and DLC Management ("DLC"), an
CNS Pharmaceuticals Announces Reverse Stock Split
08:05am, Monday, 03'rd Jun 2024
HOUSTON, TX / ACCESSWIRE / June 3, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
06:58pm, Tuesday, 28'th May 2024
NEW YORK , May 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dist
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
06:41pm, Tuesday, 28'th May 2024
NEW YORK , May 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of t
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
06:35pm, Tuesday, 28'th May 2024
NEW YORK , May 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sou
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
06:29pm, Tuesday, 28'th May 2024
NEW YORK , May 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of th
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
06:19pm, Tuesday, 28'th May 2024
NEW YORK , May 28, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of
Rapport Therapeutics Seeks IPO For CNS Treatment Programs
04:17pm, Wednesday, 22'nd May 2024
Rapport Therapeutics, Inc. has filed for a $100 million IPO to develop treatment candidates for central nervous system and related disorders. The company's lead candidate, RAP-219, is being developed
China’s 5 Biggest Military Advantages
10:04am, Monday, 20'th May 2024
In March 1999, Admiral Dennis C. Blair testified before Congress that China was not a serious threat to the United States. He claimed that it would be “several years” before the People’s Liberat
CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
08:30am, Monday, 20'th May 2024
Live webcast fireside chat on Tuesday, May 21st at 1:40 PM ET HOUSTON, TX / ACCESSWIRE / May 20, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company sp
